NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Q2 2025 revenue of €103.0 million for YORVIPATH®and €50.7 million for SKYTROFA®- TransCon® CNP (navepegritide) NDA under ...

Regulatory Reviews of Aficamten for Obstructive HCM Progressing in U.S., E.U. and China; Late-Cycle Meeting with U.S. FDA ...

The Election Commission on Thursday repudiated Jan Suraaj Party founder Prashant Kishor’s charge that the poll panel, “in ...

The Department of Defense is adding more military troops to those assigned to enforce immigration policies on the border.